Key result
Antibody binding reactivates chimaeric beta-galactosidases via distinct mechanisms, yielding a ~50% Km reduction for M278VP1.
Why the study?
The mechanisms underlying antibody-mediated enzymatic reactivation in engineered Escherichia coli beta-galactosidase molecular sensors were not fully understood.
Different beta-galactosidase probes exhibit distinct mechanisms of antibody-mediated enzymatic reactivation, involving either Km reduction or kcat variations.
Distinct mechanisms in chimaeric enzyme reactivation; hypothesis-generating for probe engineering, clinical translation unproven.
The antibody-mediated reactivation of engineered Escherichia coli beta-galactosidases [Benito et al. (1996) J. Biol. Chem. 271, 21251-21256] has been thoughtfully investigated in three recombinant molecular sensors. Proteins M278VP1, JX772A and JX795A display the highly antigenic G-H loop peptide segment of foot-and-mouth disease virus VP1 protein, accommodated in different solvent-exposed loops of the assembled tetramer. These chimaeric enzymes exhibit a significant increase in enzymatic activity upon binding of either monoclonal antibodies or sera directed against the inserted viral peptide. In JX772A but not in M278VP1, the Fab 3E5 antibody fragment promotes reactivation to the same extent as the complete antibody. On the other hand, M278VP1 Km is reduced by more than 50% in the presence of activating serum, this parameter remains invariable in JX772A and it is only slightly modified in JX795A. In these last two proteins, significant k(cat) variations can account for the increased enzymatic activity. Alternative reactivation mechanisms in the different beta-galactosidase probes are discussed in the context of the bacterial enzyme structure and its tolerance to antibody-induced conformational modifications.
No takes yet. Share an insight, caveat, or question.
Feliu et al. (1998) studied this question. Antibody-mediated reactivation was evaluated on Enzymatic activity and kinetic parameters (Km, kcat). Antibody-mediated reactivation of chimaeric beta-galactosidases occurs through distinct mechanisms, with M278VP1 showing a >50% reduction in Km, while JX772A and JX795A show significant k(cat) variations.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: